Latest filing published 15 Sept 2026 for Neurocrine Biosciences INC.
Ingrid Delaet appears at Neurocrine Biosciences Inc under the title Chief Regulatory Officer: 72 filings published from August 23, 2023 to September 15, 2026, including 34 sales and 30 option exercises. The record also holds 8 grants and no purchase.
The sales come to EUR 7,719,482, with a median of EUR 107,308, which reflects many trades of modest size. Two stand out, one day apart in July 2026: EUR 1,318,894 on July 9 and EUR 690,514 on July 10. The third, EUR 663,149, is dated March 21, 2024.
The calendar is marked by one standout year: 38 filings in 2024, against 2 in 2023, 12 in 2025 and 20 in 2026. The last twelve months hold 20, 4 of them sales.
Darin Lippoldt has 27 trades within 30 days of trades by Ingrid Delaet, Matt Abernethy 25 and Julie Cooke 23, all in the same direction. Filings are published a median of 2 days after the trade.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 72 declarations